phrykt

Biogen (BIIB) net income: $1.3B

Biogen reported a net income of $1.3B for the year ended Dec 31, 2025, down 20.8% from $1.6B a year earlier.

From Biogen's filings with the SEC · Read the filing · BIIB stock page

Biogen net income by year

$1.6B2021$3B2022$1.2B2023$1.6B2024$1.3B2025

#308 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$1.3B-21%
Dec 31, 2024$1.6B+41%
Dec 31, 2023$1.2B-62%
Dec 31, 2022$3B+96%
Dec 31, 2021$1.6B–

Net income of similar companies

Companies in the same industry as Biogen, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Biogen$1.3BDec 31, 2025
Exelixis$783MJan 2, 2026
Neurocrine Biosciences$479MDec 31, 2025
Novavax$440MDec 31, 2025
Qiagen$425MDec 31, 2025
Halozyme Therapeutics$317MDec 31, 2025
Biocryst Pharmaceuticals$264MDec 31, 2025

Questions and answers

What is Biogen's net income?

Biogen reported a net income of $1.3B for the year ended Dec 31, 2025, down 20.8% from $1.6B a year earlier.

Numbers as reported in Biogen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology